🔎 Trials Near Me

Почетна › Немалоклетни карцином плућа › Тексас › Amarillo

Kliničke studije za Немалоклетни карцином плућа u gradu Amarillo, TX

9 studija za Немалоклетни карцином плућа traži učesnike na lokacijama u gradu Amarillo i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Тражи се учесникФаза 3
  • Texas Oncology-West Texas, Amarillo
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07144280

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Тражи се учесникФаза 3
  • Texas Oncology - Amarillo Cancer Center, Amarillo
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07361497

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

Тражи се учесникФаза 3
  • Texas Oncology - Amarillo, Amarillo
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07195695

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Тражи се учесникФаза 2/3
  • Local Institution - 007-554G, Amarillo
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT04613596

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • The Don and Sybil Harrington Cancer Center, Amarillo
18 Minutes · Оба пола · Ажурирано 9. 10. 2026. · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2/3
  • The Don and Sybil Harrington Cancer Center, Amarillo
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06616584

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Тражи се учесникФаза 3
  • Texas Oncology - West Texas, Amarillo
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07222566

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

Тражи се учесникФаза 3
  • The Don and Sybil Harrington Cancer Center, Amarillo
Узраст 18 и старији · Оба пола · Ажурирано 14. 7. 2026. · NCT06686771

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • The Don and Sybil Harrington Cancer Center, Amarillo
Узраст 18 и старији · Оба пола · Ажурирано 3. 6. 2026. · NCT05642572

Studije za Немалоклетни карцином плућа u drugim gradovima

Ostale studije u gradu Amarillo

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.